首页 > 最新文献

Revista de gastroenterologia de Mexico (English)最新文献

英文 中文
Mexican consensus on the approach to and treatment of acute variceal bleeding 关于急性静脉曲张出血的方法和治疗的墨西哥共识。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.007
F. Higuera-de-la-Tijera , A. Noble-Lugo , J. Crespo , A. Albillos , A.J. Montaño-Loza , A.D. Cano-Contreras , G.E. Castro-Narro , L.F. De Giau-Triulzi , E.S. García-Jiménez , N.J. Fernández-Pérez , J.M. Aldana-Ledesma , O.E. Trujillo-Benavides , J. Cerna-Cardona , Y.M. Velasco-Santiago , E. Cerda-Reyes , D.K. Tapia-Calderón , A. Bautista-Santos , J.L. Pérez-Hernández , R. Moreno-Alcántar , J.A. Velarde-Ruiz Velasco

Introduction and aims

Portal hypertension is the main consequence of cirrhosis and the cause of most of its complications, such as ascites, variceal bleeding, and hepatic encephalopathy. The development of those complications marks the transition from compensated cirrhosis to decompensated cirrhosis, and the latter is associated with poor prognosis. Approximately 50% of cirrhotic patients have gastroesophageal varices. Acute variceal bleeding (AVB) is a medical emergency with high mortality rates ranging from 15 to 25% within 6 weeks. AVB management has evolved in recent years due to new evidence on fluid resuscitation and transfusion support, advances in endoscopic techniques, esophageal stent use, and transjugular intrahepatic portosystemic shunt (TIPS) placement. This consensus aimed to establish recommendations based on the best available evidence and expert opinion from Mexican specialists in gastroenterology for the diagnosis, management, and treatment of AVB in patients with portal hypertension. The goal was to improve clinical decision-making, reduce the associated mortality, and standardize care protocols across the different levels of medical care in Mexico.

Material and methods

Seventeen national and 3 international experts were divided into five working groups to address five thematic areas: 1) initial evaluation, 2) fluid resuscitation and initial pharmacologic therapy, 3) the role of endoscopy, 4) strategies for managing failed bleeding control, and 5) secondary prophylaxis recommendations. The consensus was developed utilizing the RAND/UCLA process, with a modified Delphi method.

Results

A total of 28 statements were produced, with specific recommendations on initial fluid resuscitation and transfusion strategy, and highlighting the importance of vasopressor use, the role of endoscopy, and AVB prophylaxis.

Conclusions

This first Mexican Consensus on Acute Variceal Bleeding establishes practical recommendations for standardizing AVB management in patients with cirrhosis in Mexico, from the initial evaluation to secondary prophylaxis, emphasizing the importance of specific strategies and laying the groundwork for future research.
简介和目的:门脉高压是肝硬化的主要后果,也是肝硬化大多数并发症的原因,如腹水、静脉曲张出血和肝性脑病。这些并发症的发生标志着代偿性肝硬化向失代偿性肝硬化的转变,而失代偿性肝硬化与预后不良有关。大约50%的肝硬化患者有胃食管静脉曲张。急性静脉曲张出血(AVB)是一种医疗紧急情况,6周内死亡率高,从15%到25%不等。近年来,由于液体复苏和输血支持的新证据、内窥镜技术的进步、食管支架的使用和经颈静脉肝内门静脉系统分流术(TIPS)的放置,AVB的管理已经发生了变化。该共识旨在根据墨西哥胃肠病学专家的最佳现有证据和专家意见,对门静脉高压症患者的AVB的诊断、管理和治疗提出建议。其目标是改善临床决策,降低相关死亡率,并使墨西哥不同医疗水平的护理方案标准化。材料和方法:17名国内专家和3名国际专家被分成5个工作组,讨论5个主题领域:1)初步评估,2)液体复苏和初始药物治疗,3)内窥镜检查的作用,4)管理出血控制失败的策略,5)二级预防建议。共识是利用兰德/加州大学洛杉矶分校的过程,用改进的德尔菲法开发的。结果:共产生了28份声明,对初始液体复苏和输血策略提出了具体建议,并强调了血管加压剂使用的重要性、内窥镜检查的作用和AVB预防。结论:这是墨西哥第一个关于急性静脉曲张出血的共识,为墨西哥肝硬化患者AVB管理的标准化提出了实用建议,从初步评估到二级预防,强调了具体策略的重要性,并为未来的研究奠定了基础。
{"title":"Mexican consensus on the approach to and treatment of acute variceal bleeding","authors":"F. Higuera-de-la-Tijera ,&nbsp;A. Noble-Lugo ,&nbsp;J. Crespo ,&nbsp;A. Albillos ,&nbsp;A.J. Montaño-Loza ,&nbsp;A.D. Cano-Contreras ,&nbsp;G.E. Castro-Narro ,&nbsp;L.F. De Giau-Triulzi ,&nbsp;E.S. García-Jiménez ,&nbsp;N.J. Fernández-Pérez ,&nbsp;J.M. Aldana-Ledesma ,&nbsp;O.E. Trujillo-Benavides ,&nbsp;J. Cerna-Cardona ,&nbsp;Y.M. Velasco-Santiago ,&nbsp;E. Cerda-Reyes ,&nbsp;D.K. Tapia-Calderón ,&nbsp;A. Bautista-Santos ,&nbsp;J.L. Pérez-Hernández ,&nbsp;R. Moreno-Alcántar ,&nbsp;J.A. Velarde-Ruiz Velasco","doi":"10.1016/j.rgmxen.2025.09.007","DOIUrl":"10.1016/j.rgmxen.2025.09.007","url":null,"abstract":"<div><h3>Introduction and aims</h3><div>Portal hypertension is the main consequence of cirrhosis and the cause of most of its complications, such as ascites, variceal bleeding, and hepatic encephalopathy. The development of those complications marks the transition from compensated cirrhosis to decompensated cirrhosis, and the latter is associated with poor prognosis. Approximately 50% of cirrhotic patients have gastroesophageal varices. Acute variceal bleeding (AVB) is a medical emergency with high mortality rates ranging from 15 to 25% within 6 weeks. AVB management has evolved in recent years due to new evidence on fluid resuscitation and transfusion support, advances in endoscopic techniques, esophageal stent use, and transjugular intrahepatic portosystemic shunt (TIPS) placement. This consensus aimed to establish recommendations based on the best available evidence and expert opinion from Mexican specialists in gastroenterology for the diagnosis, management, and treatment of AVB in patients with portal hypertension. The goal was to improve clinical decision-making, reduce the associated mortality, and standardize care protocols across the different levels of medical care in Mexico.</div></div><div><h3>Material and methods</h3><div>Seventeen national and 3 international experts were divided into five working groups to address five thematic areas: 1) initial evaluation, 2) fluid resuscitation and initial pharmacologic therapy, 3) the role of endoscopy, 4) strategies for managing failed bleeding control, and 5) secondary prophylaxis recommendations. The consensus was developed utilizing the RAND/UCLA process, with a modified Delphi method.</div></div><div><h3>Results</h3><div>A total of 28 statements were produced, with specific recommendations on initial fluid resuscitation and transfusion strategy, and highlighting the importance of vasopressor use, the role of endoscopy, and AVB prophylaxis.</div></div><div><h3>Conclusions</h3><div>This first Mexican Consensus on Acute Variceal Bleeding establishes practical recommendations for standardizing AVB management in patients with cirrhosis in Mexico, from the initial evaluation to secondary prophylaxis, emphasizing the importance of specific strategies and laying the groundwork for future research.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 451-473"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sister Mary Joseph’s nodule: Umbilical cutaneous metastasis as initial presentation of sigmoid adenocarcinoma 玛丽·约瑟夫修女结节:脐部皮肤转移是乙状体腺癌的最初表现。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.019
A. Hokama
{"title":"Sister Mary Joseph’s nodule: Umbilical cutaneous metastasis as initial presentation of sigmoid adenocarcinoma","authors":"A. Hokama","doi":"10.1016/j.rgmxen.2025.09.019","DOIUrl":"10.1016/j.rgmxen.2025.09.019","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Page 502"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The frequency of sessile serrated adenomas detected during surveillance colonoscopy in patients with a history of colorectal cancer 有结直肠癌病史的患者在结肠镜检查中发现无柄锯齿状腺瘤的频率。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.002
J.P. Pérez-Macías, J.C. Sánchez-del Monte, A.I. Hernández-Guerrero, W.D. Torrecilla-Ramírez, B.A. Sánchez-Jiménez, G.M. Salgado-Castellón

Introduction and aims

Sessile serrated adenomas (SSAs) are precursor lesions of colorectal cancer (CRC) in 15–30% of cases, but due to their subtle characteristics, their endoscopic detection is a challenge. The present work aimed to determine the frequency of SSAs in patients with a history of CRC who underwent index and surveillance colonoscopies after their cancer diagnosis.

Material and methods

An observational cohort study was conducted on patients diagnosed with CRC who underwent an index colonoscopy and at least two surveillance colonoscopies at the Instituto Nacional de Cancerología in Mexico City, between January 2015 and December 2018. Demographic and clinical variables and endoscopic findings were analyzed. SSA frequency was calculated as the number of patients with one or more SSAs divided by the total number of patients analyzed. Means were compared for the bivariate inferential analysis and the chi-square test and Fisher’s exact test were used for the nominal variable analysis. Logistic regression was carried out to search for factors related to SSA.

Results

Four hundred patients were included; the mean patient age was 58 years and 52% were women. SSA frequency was 5.25%. Thirty-three percent of the SSAs were found in the index colonoscopy and 38% in subsequent colonoscopies. SSAs had a mean size of 5.52 mm, 84% were classified as Paris Is, 45% as KUDO II, and most were located in the ascending or transverse colon (21% and 20%, respectively).

Conclusions

SSAs are rare premalignant lesions, and their endoscopic diagnosis is a challenge. Their identification during the follow-up of patients with a history of CRC is essential for reducing the risk of metachronous progression.
简介和目的:无柄锯齿状腺瘤(SSAs)是结直肠癌(CRC)的前体病变,占15-30%的病例,但由于其微妙的特征,其内镜检测是一个挑战。本研究旨在确定有结直肠癌病史的患者在癌症诊断后接受指数和监测结肠镜检查时SSAs的频率。材料和方法:在2015年1月至2018年12月期间,在墨西哥城国立医院Cancerología对诊断为结直肠癌的患者进行了一项观察性队列研究,这些患者接受了指数结肠镜检查和至少两次监测结肠镜检查。分析人口统计学和临床变量以及内窥镜检查结果。SSA频率计算为有一个或多个SSA的患者数除以所分析的患者总数。双变量推理分析采用均数比较,名义变量分析采用卡方检验和Fisher精确检验。采用Logistic回归方法寻找与SSA相关的因素。结果:纳入患者400例;患者平均年龄为58岁,52%为女性。SSA频率为5.25%。33%的ssa在第一次结肠镜检查中发现,38%在随后的结肠镜检查中发现。SSAs平均大小为5.52 mm, 84%为Paris i型,45%为KUDO II型,多数位于升结肠或横结肠(分别占21%和20%)。结论:ssa是罕见的恶性前病变,其内镜诊断是一个挑战。在对有结直肠癌病史的患者进行随访时对其进行识别对于降低异时性进展的风险至关重要。
{"title":"The frequency of sessile serrated adenomas detected during surveillance colonoscopy in patients with a history of colorectal cancer","authors":"J.P. Pérez-Macías,&nbsp;J.C. Sánchez-del Monte,&nbsp;A.I. Hernández-Guerrero,&nbsp;W.D. Torrecilla-Ramírez,&nbsp;B.A. Sánchez-Jiménez,&nbsp;G.M. Salgado-Castellón","doi":"10.1016/j.rgmxen.2025.09.002","DOIUrl":"10.1016/j.rgmxen.2025.09.002","url":null,"abstract":"<div><h3>Introduction and aims</h3><div>Sessile serrated adenomas (SSAs) are precursor lesions of colorectal cancer (CRC) in 15–30% of cases, but due to their subtle characteristics, their endoscopic detection is a challenge. The present work aimed to determine the frequency of SSAs in patients with a history of CRC who underwent index and surveillance colonoscopies after their cancer diagnosis.</div></div><div><h3>Material and methods</h3><div>An observational cohort study was conducted on patients diagnosed with CRC who underwent an index colonoscopy and at least two surveillance colonoscopies at the <em>Instituto Nacional de Cancerología</em> in Mexico City, between January 2015 and December 2018. Demographic and clinical variables and endoscopic findings were analyzed. SSA frequency was calculated as the number of patients with one or more SSAs divided by the total number of patients analyzed. Means were compared for the bivariate inferential analysis and the chi-square test and Fisher’s exact test were used for the nominal variable analysis. Logistic regression was carried out to search for factors related to SSA.</div></div><div><h3>Results</h3><div>Four hundred patients were included; the mean patient age was 58 years and 52% were women. SSA frequency was 5.25%. Thirty-three percent of the SSAs were found in the index colonoscopy and 38% in subsequent colonoscopies. SSAs had a mean size of 5.52 mm, 84% were classified as Paris Is, 45% as KUDO II, and most were located in the ascending or transverse colon (21% and 20%, respectively).</div></div><div><h3>Conclusions</h3><div>SSAs are rare premalignant lesions, and their endoscopic diagnosis is a challenge. Their identification during the follow-up of patients with a history of CRC is essential for reducing the risk of metachronous progression.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 381-387"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145034828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review: Effect of proton pump inhibitors on Helicobacter pylori physiology 系统综述:质子泵抑制剂对幽门螺杆菌生理的影响。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.003
V. Blandón-Arias , A.M. Ospina-Gil , B.E. Salazar-Giraldo , T.L. Pérez-Cala

Introduction and aims

Helicobacter pylori is a Gram-negative bacillus that colonizes the gastric mucosa and infects more than half of the world population. Treatment consists of two antibiotics and a proton pump inhibitor (PPI) that favors the replication of the bacterium and enhances the activity of the antibiotics. Despite the importance of proton pump inhibitor use in treating H. pylori infection, the precise mechanisms through which PPIs affect the physiology of the bacterium are not yet understood.

Aim

Our aim was to compile information pertaining to the effect of PPIs on the physiology of H. pylori and the mechanisms through which they produce alterations in the bacterium.

Methods

A bibliographic search was conducted, utilizing the PubMed, Science Direct, and LILACS databases, and included preclinical and clinical original articles published in any language.

Results

The sulfenamide form of PPIs was shown to have effects on H. pylori, including the induction of structural changes, inhibition of bacterial growth, and interference with enzymes, such as urease, ATPases, and alcohol dehydrogenase.

Conclusions

The binding of the sulfenamide form of PPIs to the bacterial structural and enzymatic components was the main mechanism through which H. pylori physiology was altered in vitro, but how they induce alterations in the bacterium was not established in the clinical studies analyzed.
简介与目的:幽门螺杆菌是一种定植于胃粘膜的革兰氏阴性杆菌,感染了世界上一半以上的人口。治疗包括两种抗生素和质子泵抑制剂(PPI),有利于细菌的复制和增强抗生素的活性。尽管质子泵抑制剂在治疗幽门螺杆菌感染中的重要性,但PPIs影响细菌生理的确切机制尚不清楚。目的:我们的目的是收集有关PPIs对幽门螺杆菌生理学的影响以及它们在细菌中产生改变的机制的信息。方法:利用PubMed、Science Direct和LILACS数据库进行文献检索,包括以任何语言发表的临床前和临床原始文章。结果:PPIs的磺胺形式被证明对幽门螺杆菌有影响,包括诱导结构变化,抑制细菌生长,干扰酶,如脲酶,三磷酸腺苷酶和乙醇脱氢酶。结论:PPIs的亚砜酰胺形式与细菌结构和酶的结合是体外改变幽门螺杆菌生理的主要机制,但在临床研究中尚未确定它们如何诱导细菌的改变。
{"title":"Systematic review: Effect of proton pump inhibitors on Helicobacter pylori physiology","authors":"V. Blandón-Arias ,&nbsp;A.M. Ospina-Gil ,&nbsp;B.E. Salazar-Giraldo ,&nbsp;T.L. Pérez-Cala","doi":"10.1016/j.rgmxen.2025.09.003","DOIUrl":"10.1016/j.rgmxen.2025.09.003","url":null,"abstract":"<div><h3>Introduction and aims</h3><div><em>Helicobacter pylori</em> is a Gram-negative bacillus that colonizes the gastric mucosa and infects more than half of the world population. Treatment consists of two antibiotics and a proton pump inhibitor (PPI) that favors the replication of the bacterium and enhances the activity of the antibiotics. Despite the importance of proton pump inhibitor use in treating <em>H. pylori</em> infection, the precise mechanisms through which PPIs affect the physiology of the bacterium are not yet understood.</div></div><div><h3>Aim</h3><div>Our aim was to compile information pertaining to the effect of PPIs on the physiology of <em>H. pylori</em> and the mechanisms through which they produce alterations in the bacterium.</div></div><div><h3>Methods</h3><div>A bibliographic search was conducted, utilizing the PubMed, Science Direct, and LILACS databases, and included preclinical and clinical original articles published in any language.</div></div><div><h3>Results</h3><div>The sulfenamide form of PPIs was shown to have effects on <em>H. pylori,</em> including the induction of structural changes, inhibition of bacterial growth, and interference with enzymes, such as urease, ATPases, and alcohol dehydrogenase.</div></div><div><h3>Conclusions</h3><div>The binding of the sulfenamide form of PPIs to the bacterial structural and enzymatic components was the main mechanism through which <em>H. pylori</em> physiology was altered <em>in vitro</em>, but how they induce alterations in the bacterium was not established in the clinical studies analyzed.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 388-399"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fecal microbiota transplantation in recurrent Clostridioides difficile: Is greater methodological rigor and the analysis of other populations relevant? 粪便菌群移植治疗复发性艰难梭菌:是否需要更严格的方法和对其他人群的分析?
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.022
J.A. Castrillón-Lozano , J.A. Lozano-Arce , R.L. Arroyave-Zuluaga
{"title":"Fecal microbiota transplantation in recurrent Clostridioides difficile: Is greater methodological rigor and the analysis of other populations relevant?","authors":"J.A. Castrillón-Lozano ,&nbsp;J.A. Lozano-Arce ,&nbsp;R.L. Arroyave-Zuluaga","doi":"10.1016/j.rgmxen.2025.09.022","DOIUrl":"10.1016/j.rgmxen.2025.09.022","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 506-507"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colon tumor location: Right side versus left side as a prognostic factor for colon cancer survival: Analysis of a retrospective cohort 结肠肿瘤位置:右侧与左侧是结肠癌生存的预后因素:回顾性队列分析。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.004
S.P. Molina-Meneses , L.J. Palacios-Fuenmayor , F.D. Molina-Mercado , D.F. Caycedo-Medina , R. Castaño-Llano , L.R. Gómez-Wolff , Y.E. Pérez-García

Introduction

Primary tumor location has emerged as an important prognostic factor due to different biologic characteristics.

Aim

To analyze the prognostic effect of tumor location in patients with colon cancer, comparing right-sided colon cancer with left-sided disease.

Materials and methods

A retrospective cohort study was conducted on patients above 18 years of age operated on for right-sided or left-sided colon cancer within the time frame of January 2016 and June 2022 at a quaternary care hospital. Sociodemographic and histopathologic variables were analyzed. Overall survival and progression-free survival were calculated.

Results

From a total of 247 patients, 145 (58.7%) had right-sided colon cancer and 102 (41.2%) had left-sided disease. Mean age of the right-sided tumor patients was 70 years and mean age of the left-sided tumor patients was 64 years. The majority of the patients were women. Laparoscopic surgery was performed on 71.6% of patients and most of them presented with adenocarcinoma, 68.4% of which were well differentiated tumors. Poorly differentiated tumors were more likely in the right colon than the left, with 9.7% and 0.4%, respectively. Most of the patients did not have lymph node dissemination (N0: 54.7%), but there were more positive lymph nodes (28% vs 16.5%) and more microsatellite instability (48 vs 4 patients) in right-sided tumors. Fifty-three patients presented with metastasis, with no differences regarding laterality. Forty-four patients with right-sided cancer and 18 with left-sided cancer died. Right-sided location was the independent risk variable for overall survival (HR:1.97 [1.10–3.53]). Perineural invasion, metastasis, and disease stage were independent risk variables. Laterality was not a factor in progression-free survival.

Conclusion

Tumor located in the right colon was an independent risk factor impacting overall survival in colon cancer.
由于不同的生物学特性,原发肿瘤的位置已成为一个重要的预后因素。目的:分析肿瘤部位对结肠癌患者预后的影响,比较右侧结肠癌与左侧结肠癌的差异。材料与方法:回顾性队列研究于2016年1月至2022年6月在某四级护理医院进行的18岁以上右侧或左侧结肠癌手术患者。分析社会人口学和组织病理学变量。计算总生存期和无进展生存期。结果:247例患者中,145例(58.7%)为右侧结肠癌,102例(41.2%)为左侧结肠癌。右侧肿瘤患者平均年龄70岁,左侧肿瘤患者平均年龄64岁。大多数患者是女性。71.6%的患者行腹腔镜手术,以腺癌为主,其中68.4%为高分化肿瘤。低分化肿瘤在右结肠的发生率高于左结肠,分别为9.7%和0.4%。多数患者未见淋巴结播散(N0: 54.7%),但右侧肿瘤中淋巴结阳性较多(28%比16.5%),微卫星不稳定较多(48比4)。53例患者出现转移,侧边无差异。44名右侧癌症患者和18名左侧癌症患者死亡。右侧位置是总生存的独立危险变量(HR:1.97[1.10-3.53])。神经周围浸润、转移和疾病分期是独立的危险变量。侧边性不是无进展生存期的一个因素。结论:肿瘤位于右结肠是影响结肠癌总生存的独立危险因素。
{"title":"Colon tumor location: Right side versus left side as a prognostic factor for colon cancer survival: Analysis of a retrospective cohort","authors":"S.P. Molina-Meneses ,&nbsp;L.J. Palacios-Fuenmayor ,&nbsp;F.D. Molina-Mercado ,&nbsp;D.F. Caycedo-Medina ,&nbsp;R. Castaño-Llano ,&nbsp;L.R. Gómez-Wolff ,&nbsp;Y.E. Pérez-García","doi":"10.1016/j.rgmxen.2025.09.004","DOIUrl":"10.1016/j.rgmxen.2025.09.004","url":null,"abstract":"<div><h3>Introduction</h3><div>Primary tumor location has emerged as an important prognostic factor due to different biologic characteristics.</div></div><div><h3>Aim</h3><div>To analyze the prognostic effect of tumor location in patients with colon cancer, comparing right-sided colon cancer with left-sided disease.</div></div><div><h3>Materials and methods</h3><div>A retrospective cohort study was conducted on patients above 18 years of age operated on for right-sided or left-sided colon cancer within the time frame of January 2016 and June 2022 at a quaternary care hospital. Sociodemographic and histopathologic variables were analyzed. Overall survival and progression-free survival were calculated.</div></div><div><h3>Results</h3><div>From a total of 247 patients, 145 (58.7%) had right-sided colon cancer and 102 (41.2%) had left-sided disease. Mean age of the right-sided tumor patients was 70 years and mean age of the left-sided tumor patients was 64 years. The majority of the patients were women. Laparoscopic surgery was performed on 71.6% of patients and most of them presented with adenocarcinoma, 68.4% of which were well differentiated tumors. Poorly differentiated tumors were more likely in the right colon than the left, with 9.7% and 0.4%, respectively. Most of the patients did not have lymph node dissemination (N0: 54.7%), but there were more positive lymph nodes (28% vs 16.5%) and more microsatellite instability (48 vs 4 patients) in right-sided tumors. Fifty-three patients presented with metastasis, with no differences regarding laterality. Forty-four patients with right-sided cancer and 18 with left-sided cancer died. Right-sided location was the independent risk variable for overall survival (HR:1.97 [1.10–3.53]). Perineural invasion, metastasis, and disease stage were independent risk variables. Laterality was not a factor in progression-free survival.</div></div><div><h3>Conclusion</h3><div>Tumor located in the right colon was an independent risk factor impacting overall survival in colon cancer.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 400-411"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in risk factors, demographic and clinicopathologic characteristics at diagnosis between proximal and distal colon cancer: A multicenter retrospective cohort analysis 近端和远端结肠癌诊断时危险因素、人口学和临床病理特征的差异:一项多中心回顾性队列分析。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.001
R.A. Muñoz , F.J. Miranda , A.A. Ramírez , D. Regalado , J.C. Ortiz , G. Gallardo , S. Pizarro

Introduction and aims

There are differences, with genetic and embryologic support, in the clinical behavior of proximal colon cancer (PCC) (right colon: cecum, ascending colon, and transverse colon) and distal colon cancer (DCC) (left colon: descending colon, sigmoid colon, rectum). Our aim was to determine whether there was a divergent pattern in the demographic characteristics, risk factors, TNM stage, and clinical stage at diagnosis between patients with PCC and those with DCC.

Material and methods

A retrospective, analytic, and multicenter study was conducted. Medical records of patients diagnosed with colorectal cancer, confirmed by histopathology and with TNM staging, within the time frame of 2018-2023, were collected from two hospital centers in the city of Chihuahua. They were divided into the PCC and DCC groups, for evaluating the abovementioned characteristics.

Results

From a total of 513 cases, 404 were included in the study. Significant differences were found in the demographic characteristics of female sex and a history of cholecystectomy, both with a greater relative frequency for PCC. Distant metastasis was present in 35.6% of patients, despite their younger age at diagnosis. The rectum was the most commonly affected segment in the DCC group, as was the ascending colon in the PCC group. There was a greater prevalence of peritoneal carcinomatosis in the PCC group. In contrast, the DCC group had a greater prevalence of distant metastasis to other organs, as both individual metastasis (M1a) and multiple site metastasis (M1b). There were no considerable differences in the KRAS, NRAS, or BRAF gene mutations between the two groups.

Conclusions

PCC was associated with a history of cholecystectomy and female sex and had more aggressive TNM staging, compared with DCC.
简介和目的:在遗传学和胚胎学的支持下,近端结肠癌(PCC)(右结肠:盲肠、升结肠和横结肠)和远端结肠癌(DCC)(左结肠:降结肠、乙状结肠、直肠)的临床行为存在差异。我们的目的是确定PCC和DCC患者在人口学特征、危险因素、TNM分期和诊断时的临床分期方面是否存在差异。材料与方法:采用回顾性、分析性、多中心研究。从奇瓦瓦市的两家医院中心收集了2018-2023年期间经组织病理学证实并有TNM分期的结直肠癌患者的医疗记录。将其分为PCC组和DCC组,以评价上述特征。结果:513例患者中,404例纳入研究。在女性的人口学特征和胆囊切除术史上发现了显著的差异,两者都有更高的PCC的相对频率。35.6%的患者存在远处转移,尽管他们在诊断时年龄较小。直肠是DCC组中最常见的受累部位,PCC组中升结肠也是如此。PCC组腹膜癌发病率较高。相比之下,DCC组有更高的远处转移到其他器官的患病率,无论是个体转移(M1a)还是多部位转移(M1b)。KRAS、NRAS或BRAF基因突变在两组之间没有显著差异。结论:与DCC相比,PCC与胆囊切除术史和女性相关,并且具有更积极的TNM分期。
{"title":"Differences in risk factors, demographic and clinicopathologic characteristics at diagnosis between proximal and distal colon cancer: A multicenter retrospective cohort analysis","authors":"R.A. Muñoz ,&nbsp;F.J. Miranda ,&nbsp;A.A. Ramírez ,&nbsp;D. Regalado ,&nbsp;J.C. Ortiz ,&nbsp;G. Gallardo ,&nbsp;S. Pizarro","doi":"10.1016/j.rgmxen.2025.09.001","DOIUrl":"10.1016/j.rgmxen.2025.09.001","url":null,"abstract":"<div><h3>Introduction and aims</h3><div>There are differences, with genetic and embryologic support, in the clinical behavior of proximal colon cancer (PCC) (right colon: cecum, ascending colon, and transverse colon) and distal colon cancer (DCC) (left colon: descending colon, sigmoid colon, rectum). Our aim was to determine whether there was a divergent pattern in the demographic characteristics, risk factors, TNM stage, and clinical stage at diagnosis between patients with PCC and those with DCC.</div></div><div><h3>Material and methods</h3><div>A retrospective, analytic, and multicenter study was conducted. Medical records of patients diagnosed with colorectal cancer, confirmed by histopathology and with TNM staging, within the time frame of 2018-2023, were collected from two hospital centers in the city of Chihuahua. They were divided into the PCC and DCC groups, for evaluating the abovementioned characteristics.</div></div><div><h3>Results</h3><div>From a total of 513 cases, 404 were included in the study. Significant differences were found in the demographic characteristics of female sex and a history of cholecystectomy, both with a greater relative frequency for PCC. Distant metastasis was present in 35.6% of patients, despite their younger age at diagnosis. The rectum was the most commonly affected segment in the DCC group, as was the ascending colon in the PCC group. There was a greater prevalence of peritoneal carcinomatosis in the PCC group. In contrast, the DCC group had a greater prevalence of distant metastasis to other organs, as both individual metastasis (M1a) and multiple site metastasis (M1b). There were no considerable differences in the KRAS, NRAS, or BRAF gene mutations between the two groups.</div></div><div><h3>Conclusions</h3><div>PCC was associated with a history of cholecystectomy and female sex and had more aggressive TNM staging, compared with DCC.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 373-380"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unanticipated encounter with Ascaris lumbricoides during endoscopic bile duct stone removal: A case report 内镜下胆管结石取出术中意外遇到蛔虫一例报告。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.012
S. Gómez-Jordan , A. Sepúlveda , A. Montes , N. Forti-Sosa
{"title":"Unanticipated encounter with Ascaris lumbricoides during endoscopic bile duct stone removal: A case report","authors":"S. Gómez-Jordan ,&nbsp;A. Sepúlveda ,&nbsp;A. Montes ,&nbsp;N. Forti-Sosa","doi":"10.1016/j.rgmxen.2025.09.012","DOIUrl":"10.1016/j.rgmxen.2025.09.012","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 479-480"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastrointestinal manifestations in hereditary transthyretin amyloidosis: A case report 遗传性甲状腺转蛋白淀粉样变的胃肠道表现1例。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.015
J.C. Peñafort-Zamora , A.C. Zamora-García , H. Hernández-Cortes , J.A. Pérez-Ríos , S. Villalon-Ávalos
{"title":"Gastrointestinal manifestations in hereditary transthyretin amyloidosis: A case report","authors":"J.C. Peñafort-Zamora ,&nbsp;A.C. Zamora-García ,&nbsp;H. Hernández-Cortes ,&nbsp;J.A. Pérez-Ríos ,&nbsp;S. Villalon-Ávalos","doi":"10.1016/j.rgmxen.2025.09.015","DOIUrl":"10.1016/j.rgmxen.2025.09.015","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 486-488"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: Adenocarcinoma of the rectum with implantation metastasis in the perianal region 病例报告:直肠腺癌伴肛周移植物转移。
Pub Date : 2025-07-01 DOI: 10.1016/j.rgmxen.2025.09.017
F. Barreda , R. Cruz , H. Benites-Goñi , C. Barreda , J. Alférez
{"title":"Case report: Adenocarcinoma of the rectum with implantation metastasis in the perianal region","authors":"F. Barreda ,&nbsp;R. Cruz ,&nbsp;H. Benites-Goñi ,&nbsp;C. Barreda ,&nbsp;J. Alférez","doi":"10.1016/j.rgmxen.2025.09.017","DOIUrl":"10.1016/j.rgmxen.2025.09.017","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 491-492"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de gastroenterologia de Mexico (English)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1